Empa/Lina FDC Food Effect Study (Japan)
NCT02815644
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
empagliflozin/linagliptin FDC
Sponsor
Boehringer Ingelheim